Correspondence on "Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions" by Lavelle et al

Genet Med. 2022 Dec;24(12):2595-2596. doi: 10.1016/j.gim.2022.08.030. Epub 2022 Sep 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Base Sequence
  • Child
  • Cost-Benefit Analysis
  • Exome Sequencing
  • Exome* / genetics
  • Humans
  • Rare Diseases* / diagnosis
  • Rare Diseases* / genetics
  • Sequence Analysis, DNA